Answer
Women of childbearing potential must use reliable contraception during treatment with cipaglucosidase alfa in combination with miglustat and for 4 weeks after discontinuing treatment.
Sources for this answer
- Pombiliti 105 mg powder for concentrate for solution for infusionAmicus Therapeutics UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked